IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
79 hedge funds and large institutions have $186M invested in IGM Biosciences in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.66% less ownership
Funds ownership: 71.55% → 67.89% (-3.7%)
10% less capital invested
Capital invested by funds: $208M → $186M (-$21.3M)
Holders
79
Holding in Top 10
–
Calls
$145K
Puts
$9K
Top Buyers
| 1 | +$3.79M | |
| 2 | +$1.69M | |
| 3 | +$1.65M | |
| 4 |
First Manhattan
New York
|
+$1.44M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.04M |
Top Sellers
| 1 | -$3.96M | |
| 2 | -$1.81M | |
| 3 | -$1.8M | |
| 4 |
D.E. Shaw & Co
New York
|
-$832K |
| 5 |
Renaissance Technologies
New York
|
-$711K |